SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-004955
Filing Date
2022-02-07
Accepted
2022-02-07 08:26:53
Documents
2
Period of Report
2022-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1544
2 EX-24 DOCUMENT attachment1.htm EX-24 4073
  Complete submission text file 0000899243-22-004955.txt   7016
Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 6 BEDMINSTER NJ 07921
Business Address
THERO JOHN F (Reporting) CIK: 0001199637 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40499 | Film No.: 22595552

Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences